DIN 02554437 — BAXDELA 300 MG
BAXDELA is a powder for solution of Delafloxacin marketed by XEDITON PHARMACEUTICALS INC. The full Delafloxacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02554437
- Brand name
- BAXDELA
- Active ingredient
- Delafloxacin
- Strength
- 300 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- XEDITON PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Fluoroquinolone antibacterial
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Delafloxacin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02554429 | BAXDELA | 450 MG | TABLET | XEDITON PHARMACEUTICALS INC | MARKETED |